The renal resistance vessels of the mature spontaneously hypertensive rat (SHR) exhibit increased reactivity to vasoconstrictor agonists. This could be a cause or consequence of hypertension. We have compared vascular reactivity in isolated perfused kidneys from 46-day-old SHR and from normotensive control rats. The amplitude of responses in kidneys from the SHR to angiotensin II, barium chloride, or norepinephrine was not different from the control. Therefore, increased reactivity of the renal vascular smooth muscle cannot be an early pathogenic mechanism in spontaneous hypertension. Responses evoked by 5-hydroxytryptamine (serotonin) were of a greater amplitude in the SHR than in the control kidney. However, this difference was due to an interaction of serotonin with the sympathetic nerves, as it was abolished by treatment of the rats with 6-hydroxydopamine. Responses induced by electrical stimulation of the renal sympathetic nerves were also of greater amplitude in SHR than in control kidneys, both before and after the blockade of norepinephrine disposition mechanisms. Nerve stimulation evoked a greater efflux of endogenous norepinephrine from kidneys of the SHR than from those of control rats. Thus, the increased reactivity of the SHR kidney to renal nerve stimulation is due to an augmented release of endogenous norepinephrine. This could be an important factor in the early development of hypertension. 
" 8 Such increases in vascular reactivity may be secondary to sustained hypertension. 9 ' 10 If they were to occur in the early stages of hypertension, however, they could be important in the pathogenesis of the process. 11 In the present study, we have examined vascular reactivity to exogenous agonists and to nerve stimulation in kidneys from young SHR in which hypertension was developing.
Methods
The following strains of rat were used: spontaneously hypertensive rats of the Japanese strain, 4 normotensive Wistar-Kyoto (WK.Y) rats from which the SHR was developed, and inbred normotensive Wistar rats. Only male animals were used as there are important sex-related differences in the SHR. 8 The perfusion pressure responses of kidneys from normotensive WKY and inbred Wistar rats to a variety of vasoconstrictor stimuli were not consistently significantly different (table 1) . Conse- quently, each group of control rats was made up of approximately equal numbers of animals from the two normotensive strains. Control animals of similar age were weight-matched with the SHR.
The systolic blood pressure of the rats was measured by an indirect tail-cuff method 12 in the unanesthetized animal.
Isolated Perfused Kidney Preparation
Rats were anesthetized with pentobarbitone-sodium (50 mg/kg, i.p.) and the abdomen opened by midline incision. The right renal artery, the left spermatic artery, and the left suprarenal artery were ligated. A cannula was inserted into the aorta rostral to the renal arteries and positioned with its tip adjacent to the left renal artery. The cannula was secured by a ligature, and the aorta caudal to the left renal artery was tied off and cut. The left kidney and cannulated segment of the aorta were removed from the animal and placed in a chamber containing Tyrode's solution at 37°C. This procedure interrupted the blood supply to the kidney for 15 to 30 seconds while the cannula was inserted, and before perfusion with Tyrode's solution was commenced.
The isolated kidney was perfused with Tyrode's solution (37°C), using a constant flow roller pump (Gilson, Minipuls II). Renal vasoconstrictor responses were recorded as increases in perfusion pressure, downstream from the pump.
Electrodes placed around the renal artery were used to stimulate the renal nerves (Janssen Scientific Instruments, Universal stimulator). Optimum perfusion conditions were determined for each kidney by stepwise increases in perfusion flow rate. A standard electrical stimulus (16 Hz, 10-sec duration every 4 min) was given at each flow rate. The minimum perfusion flow rate that permitted a maximal constrictor response was taken as optimum, and used thereafter. An equilibration period of 30-45 minutes was allowed before commencing the experiments.
Frequency-response curves to electrical stimulation were obtained by increasing frequencies (2-16 Hz) of stimulation (10 V, 2 msec pulse width) for periods of 20 or 60 seconds every 4 minutes. Dose-response curves to exogenous agonists and ions were made by rapidly injecting constant volumes (0.02 ml for agonists, 0.1 ml for ions) into the perfusion system, close to the kidney, in the following order: norepinephrine, 5-hydroxytryptamine, barium chloride, and angiotensin II amide. Injection of these volumes caused a small, transient increase in perfusion pressure, which preceded the agonist-evoked response. This injection artifact was the only change in perfusion pressure observed when Tyrode's solution was injected into the system.
The minimum time between successive doses of agonist was 2 minutes for norepinpehrine, 5-hydroxytryptamine, and barium chloride, and 8 minutes for angiotensin II. When necessary, these time periods were extended until the previous response had disappeared.
Kidneys from SHR and control rats were perfused in parallel, with the same solutions in 85% of the experiments. 8 
Measurement of Catecholamine Efflux from Perfused Kidneys
In certain experiments, kidneys from SHR and control rats were perfused at a constant flow rate of 2 ml/min and the perfusate collected for 2-minute periods into cooled tubes containing 7.6 mg EGTA and 4.8 mg reduced glutathione. The perfusates collected immediately before and during 2-minute periods of electrical stimulation (6 and 16 Hz) were analyzed for norepinephrine, epinephrine, and dopamine by the radio-enzymatic method described by Peuler and Johnson." In a previous study we have demonstrated that the sensitivity of this assay is 3 pg for norepinephrine, 2 pg for epinephrine, and 5 pg for dopamine.
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Treatment of Rats with 6-Hydroxydopamine
In certain experiments, the SHR and control rats were treated with 6-hydroxydopamine (200 mg/kg, i.v.) 18 hours before kidney perfusion. Periarterial electrical stimulation (16 Hz, 60-sec duration) was used to assess the degree of damage to the sympathetic nerves caused by this treatment.
Drugs Used
The following drugs and chemicals were used: angiotensin II amide (CIBA), barium chloride (Merck), cocaine hydrochloride (Bios), 6-hydroxydopamine hydrochloride (Astra), 5-hydroxytryptamine creatinine sulphate (Cal-Biochem), (-) norepinephrine bitartrate (Fluka), (±) normetanephrine hydrochloride (Cal-Biochem), pargyline hydrochloride (Abbott), and pyrogallol (Aldrich).
Doses of norepinephrine and 5-hydroxytryptamine are expressed as base; those of angiotensin II amide and barium chloride as salt.
Analysis of Results
Data are expressed as mean ± SEM throughout this paper. Significant differences (p < 0.05) between means were evaluated using Student's t test.
Results
The mean age of the SHR used in this study was 46.1 ± 1.5 days (n = 30). At this age, the systolic blood pressure of the SHR was significantly greater than that of the control rats (table 2) . The weight, optimal flow rate, and basal perfusion pressures of the kidneys from SHR and from control rats were not different (table 2) . Data are mean values = * = SEM. 'Significantly different from control (p < fml/g of kidney weight/min.
0.05).
Renal Nerve Stimulation
Renal nerve stimulation (either 60-or 20-sec train duration) was applied to kidneys from two groups of animals each comprised of equal numbers of SHR and control rats. The constrictor responses evoked by 6, 8, 10, and 12 Hz stimulation (20-or 60-sec duration) were of significantly greater amplitude in kidneys from SHR than from control rats (figs. 1 and 2). The response evoked by a 16 Hz stimulus of 20-second but not of 60-second duration was of greater amplitude in SHR than in control kidneys.
The involvement of norepinephrine disposition mechanisms in the increased reactivity of the SHR kidney to renal nerve stimulation was investigated by perfusing SHR (n = 7) and control kidneys (n = 7) with Tyrode's solution containing cocaine (10"" M), normetanephrine (10~5 M), pargyline (5 X 10" 8 M), and pyrogallol (5 X lO"4 M) for 30 minutes. This caused a significant increase in the amplitude of responses evoked by nerve stimulation (20-sec duration) at 2, 4, 6, 10, and 12 Hz in kidneys from control rats; and at 2, 4, 6, and 8 Hz for the SHR. The shift to the left of the frequency-response curve caused by this treatment was of similar magnitude in kidneys from the two groups of animals ( fig. 2) . After the blockade of norepinephrine disposition mechanisms, the responses of kidneys from the SHR were still significantly greater than those of the control rats at 4, 8, 10, 12, and 16 Hz (fig. 2) .
The basal (unstimulated) efflux of norepinephrine from SHR kidneys was not significantly different from that of control kidneys (table 3) . Electrical stimulation of the renal sympathetic nerves at 6 or 16 Hz evoked a large increase in the efflux of norepinephrine. The stimulus-evoked efflux of norepinephrine was significantly larger from SHR than from control kidneys at both 6 and 16 Hz (table  3) . The amplitude of the vasoconstrictor responses evoked by electrical stimulation was also greater in the kidneys from the SHR than from the control rats 
FIGURE 1. Left: Periarterial electrical stimulation frequency response curves in kidneys from voung SHR and control rats. Right: Log dose-response curves to norepinephrine in kidneys from young SHR and control rats. Mean increases in perfusion pressure (± SEM) of kidneys from SHR (circles, n = 6) and from normotensive control rats (squares, n = 6). Significant differences (p < 0.05) between kidneys from SHR and control rats are indicated by asterisks.
FIGURE 2. Periarterial electrical stimulation frequency-response curves in kidneys from young SHR and control rats, before (continuous lines) and after (broken lines) blockade of norepinephrine disposition mechanisms. Mean (± SEM) increases in perfusion pressure of kidneys from SHR (circles, n = 7) and from normotensive control rats (squares, n = 7). Significant differences (p < 0.05) in responses before and after blockade of disposition mechanisms are indicated by asterisks. Exclamation marks indicate a significantly different (p < 0.05) response of SHR kidneys from that of normotensive controls.
(table 3). No dopamine or epinephrine could be detected in the perfusate from stimulated or unstimulated kidneys.
Angiotensin II, Barium Chloride, and Norepinephrine There was no significant difference in the amplitude of responses evoked by norepinephrine ( fig. 1) , by angiotensin II, or by barium chloride ( fig. 3 ) in kidneys from SHR and control rats. After the blockade of norepinephrine disposition mechanisms (see above), the sensitivity of kidneys from SHR and control rats to this agonist was not different (-LogEDso values (g): SHR = 7.08 ± 0 . 1 ; control = 7,18 ±0.08).
5-Hydroxytryptamine
Constrictor responses evoked by submaximal and maximal doses of 5-hydroxytryptamine were of significantly greater amplitude in kidneys from SHR than from control rats ( fig. 4, left) . This increased reactivity of the renal resistance vessels could be due to an interaction of the amine with adrenergic nerve endings. This was investigated in kidneys from SHR and control rats that had been treated with 6-hydroxydopamine. The mean (± SEM) response amplitudes evoked by renal nerve stimulation in kidneys from untreated SHR and control rats were 212.8 ± 17.5 and 190.7 ± 21.7 mm Hg respectively. The mean response amplitudes evoked in 6-hydroxydopamine-treated SHR and control rats were 13.2 ± 4.8 and 14.7 ± 3.4 mm Hg respectively. After 6-hydroxydopamine treatment, there was no significant difference between the amplitude of submaximal responses evoked by 5-hydroxytryptamine in SHR and control kidneys (fig. 4, right) . The maximal response evoked by 5-hydroxytryptamine in kidneys from treated SHR was still significantly greater than in the treated control ( fig. 4, right) . 
FIGURE 3. Left: Log dose-response curves to barium chloride fn = 6). Right: Log-dose response curves to angiotensin II (n = II). Mean increases in perfusion pressure (± SEM) of kidneys from SHR (circles) and from control rats (squares).
FIGURE 4. Left: Log dose-response curves to 5-hydroxytryptamine in kidneys from SHR and control rats, before treatment with 6-hydroxydopamine. Right: After treatment. Mean increases in perfusion pressure (± SE/nj of kidneys from SHR (circles, n = 6) and control rats (squares, n = 6). Significant differences (p < 0.05) between kidneys from SHR and control rats are indicated by asterisks.
Discussion
The aim of this study was to evaluate vascular reactivity in perfused kidneys from young SHR, since early alterations could be of importance in the development of high blood pressure. The SHR used in this study were in the developmental phase of hypertension, as their systolic blood pressure was significantly greater than in the control, but had not reached the high levels (220 mm Hg) observed in the mature male animal. 8 The results indicate that the isolated renal vascular smooth muscle of the young SHR responds normally to most exogenous agonists, but that the function of the post-ganglionic sympathetic nerve is altered. The reactivity of the renal sympathetic nerves and vasculature may be further modulated by hormonal factors in vivo.
Renal Vascular Smooth Muscle
Previous studies have shown that renal vasoconstrictor responses evoked by angiotensin II, barium chloride, and norepinephrine are not depressed by reserpine or 6-hydroxydopamine pretreatment. 8 Consequently, these responses must be due to the direct or receptor-mediated stimulation of the vascular smooth muscle, rather than to the release of endogenous catecholamines. The amplitudes of the responses evoked by these vasoconstrictor agents were not significantly different in kidneys from the young SHR and from control rats. This indicates that increased reactivity of the renal vascular smooth muscle is unlikely to be a primary pathogenic mechanism in the 46-day-old SHR, unless it is caused by bloodborne factors. In addition, the increased renal reactivity previously found in the mature (4-to 6-monthold) SHR 8 must be a consequence of hypertension. In a recent study of vascular reactivity in the perfused hindquarters preparation from young (3-to 5-week-old) rats, Lais and Brody 11 reported increased vascular reactivity to both norepinephrine and barium chloride in the SHR and an increase in the basal resistance to flow. 11 In the present study, there was no difference in these parameters in kidneys from young SHR and control rats. One explanation of this paradox is based on the report that skeletal muscle arterioles are fewer in the SHR.
1S Such a rarification of the vessels could cause increases in both basal resistance and in the reactivity to exogenous agonists in a vascular bed that contains skeletal muscle, such as the hindquarters, but not in the kidney. Alternatively, two different substrains of SHR are being compared in which the etiology of hypertension is different.
Renal Sympathetic Nerres
Periarterial electrical stimulation of the perfused kidney preparation activates sympathetic nerves that release norepinephrine. 8 The constrictor responses evoked by renal nerve stimulation in kidneys from the young SHR were of greater amplitude than the control. This could be due to 1) supersensitivity of the postsynaptic a-adrenoceptor; 2) a reduced rate of transmitter (norepinephrine) disposition; or 3) a greater release of endogenous norepinephrine.
An alteration in the postsynaptic a-adrenoceptor is unlikely in view of the normal responsiveness of the vascular smooth muscle to exogenous norepinephrine both before and after the blockade of norepinephrine disposition mechanisms.
If the norepinephrine disposition mechanisms are less effective in the kidney of the SHR than of the control animal, then inhibition of these mechanisms should potentiate responses evoked by renal nerve stimulation to a greater extent in the latter and thus reduce or abolish the difference in response amplitude between SHR and control kidneys. However, treatment with cocaine, normetanephrine, pargyline, and pyrogallol potentiated the amplitude of responses to renal nerve stimulation to a similar extent in kidneys from both SHR and control rats. These results indicate that there is no important difference between the disposition of endogenous norepinephrine in kidneys from young SHR and control rats.
The increased reactivity of the kidney of the young SHR to renal nerve stimulation is therefore most likely to be a consequence of a greater-than-normal release of endogenous norepinephrine from the sympathetic nerves. This suggestion is strongly supported by the greater efflux of endogenous norepinephrine which was evoked' by renal nerve stimulation in kidneys from the SHR than from the control rat. The reason for this enhanced efflux of norepinephrine cannot be determined from the present experiments. However, there is evidence both of an increased renal norepinephrine content and of a larger area of catecholamine fluorescence around the arterioles in the young SHR. 18 -17 This could be due to an enhanced norepinephrine synthesis by each nerve terminal or to a larger number of adrenergic nerve varicosities in the SHR. Either of these alterations could cause an increased release of norepinephrine in response to electrical stimulation of the renal sympathetic nerves.
5-Hydroxytryptamine
5-Hydroxytryptamine can evoke constriction of blood vessels both by a direct action on the vascular smooth muscle cell and indirectly by being taken up and releasing or displacing norepinephrine from sympathetic nerve endings. 18 When the sympathetic nerves of the SHR and the control rats were severely damaged by treatment with 6-hydroxydopamine, the increased reactivity of the SHR kidney to submaximal doses of this agonist was abolished. This implies that increased reactivity to 5-hydroxytryptamine in the young SHR is due mainly to an altered interaction of the amine with the sympathetic nerve terminal, rather than with the vascular smooth muscle cell. The persistence of the increased maximum response to 5-hydroxytryptamine in the young SHR after 6-hydroxydopamine treatment may be due to the fact that nerve destruction, although pronounced, was not complete, as evidenced by the small residual response to renal nerve stimulation. The nature of the altered interaction of 5-hydroxytryptamine with the sympathetic nerves of the young SHR is not known. It could involve an alteration in the neuronal uptake of 5-hydroxytryptamine 19 ' 2° or a greater release of norepinephrine by serotonin. 21 ' " The major finding of this study is that the kidney of the 46-day-old SHR exhibits increased reactivity to renal nerve stimulation, as a consequence of a greater than normal release of norepinephrine. This early alteration in the sympathetic nerve could be an important factor in causing increased renal vascular resistance and elevated plasma renin activity of the young SHR."' 2 < In addition, a neurogenically mediated increase in renal vascular resistance may be an important factor in causing hypertension, as renal denervation in the young SHR is known to delay the development of high blood pressure.
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